U.S. Oil and Gas Stock News

NYSE:WLK
NYSE:WLKChemicals

Is Westlake (WLK) Fairly Valued After Its Dutch Court Win?

Westlake (WLK) moved back into focus for investors after a Dutch court dismissed two large ethylene antitrust lawsuits against the company, while twelve related cases in Europe are still progressing. See our latest analysis for Westlake. Westlake shares trade at $71.72 after a 1-day share price decline of 0.73% and a 90-day share price decline of 37.63%, while the 1-year total shareholder return has fallen 7.16%. This points to fading momentum despite the recent legal win and upcoming...
NYSE:ECL
NYSE:ECLChemicals

Is Ecolab (ECL) Undervalued Following Its 11% EPS Rise?

Ecolab (ECL) is back in focus after reporting an 11% rise in adjusted EPS, supported by 5% organic sales growth, improved pricing, and strong contributions from Life Sciences and Global High Tech. See our latest analysis for Ecolab. The recent earnings and ongoing share repurchases have come alongside a share price of US$279.34, with a 7.64% 90 day share price return and a 58.80% three year total shareholder return that signals sustained momentum around Ecolab’s long term story. If Ecolab’s...
NYSE:AWR
NYSE:AWRWater Utilities

How Investors Are Reacting To American States Water’s (AWR) 8.2% Dividend Increase And 72-Year Streak

American States Water Company recently approved an increase in its third-quarter cash dividend to US$0.5455 per share from US$0.5040, lifting the annualized dividend to US$2.182 per share, an 8.2% rise, payable on September 2, 2026 to shareholders of record on August 17, 2026. This marks the company’s 361st consecutive dividend payment and extends its 72-year streak of annual dividend increases, highlighting a rare level of income consistency in the utilities sector. Next, we’ll examine how...
NYSE:YUMC
NYSE:YUMCHospitality

Yum China (YUMC) Is Up 7.8% After Earnings Beat, Buybacks And Pizza Hut Expansion Plans

Yum China Holdings, Inc. reported past second-quarter 2026 results with revenue rising to US$3,138 million and net income to US$244 million, while also continuing its long-running share repurchase program and declaring a US$0.29 per-share cash dividend. An interesting angle for investors is how higher earnings per share, ongoing buybacks that have retired over a quarter of shares, and brand ownership moves like acquiring Pizza Hut in Mainland China may collectively shape Yum China’s capital...
NYSE:HAL
NYSE:HALEnergy Services

Is Halliburton (HAL) Undervalued On Earnings, Buybacks, And Its Australian AI Data Center MOU?

Halliburton (HAL) stock is back in focus after the company released second quarter 2026 results, reported a fresh tranche of share repurchases, and advanced a new memorandum of understanding tied to an Australian gas powered AI data center project. See our latest analysis for Halliburton. At a share price of $31.64, Halliburton has seen its 90 day share price return fall 24.05%, even as the 1 year total shareholder return sits at 44.53%. Recent earnings, buybacks, and the Australian AI data...
NYSE:EFX
NYSE:EFXProfessional Services

Equifax (EFX) Could Be 19% Below Fair Value Following Raised Guidance

Equifax (EFX) is back in focus after its latest quarterly results, updated guidance, and a fresh fixed income financing, all arriving alongside expense concerns and a US$2.2 million settlement over credit reporting errors. See our latest analysis for Equifax. Equifax’s recent 10.97% 1 month share price return contrasts with a year to date share price decline of 17.71% and a 1 year total shareholder return decline of 25.91%. This points to a rebound in momentum after earlier weakness. If you...
NYSE:MAIN
NYSE:MAINCapital Markets

Main Street Capital (MAIN) Could Be 5% Undervalued On August 6 Earnings Watch

Upcoming Earnings Put Main Street Capital in Focus Main Street Capital (MAIN) heads into its August 6 earnings report with forecasts calling for higher year over year earnings but slightly lower revenue, which keeps attention on how closely results track existing expectations. See our latest analysis for Main Street Capital. At a share price of $54.44, Main Street Capital has seen its recent momentum cool, with the share price return down 11.84% year to date, although the 5 year total...
NYSE:KVYO
NYSE:KVYOSoftware

AI Stocks to Watch Now for Software Growth and Data Center Demand

Artificial intelligence sits at the crossroads of powerful themes right now, from central banks watching inflation to businesses pushing for productivity gains. While policy signals from the Fed, ECB and BoJ keep markets focused on inflation, services and energy costs, the AI Stocks screener zeroes in on companies directly tied to the ChatGPT and AI build out in semiconductors, software, LLMs, cloud and digital transformation. This article walks through that theme in clear terms and...
NYSE:ESNT
NYSE:ESNTDiversified Financial

Essent Group (ESNT) Options Heat Up, Is The Stock Fairly Valued?

Recent options trading in Essent Group (ESNT) has pushed implied volatility on the October 16, 2026 $85 call contract to the higher end of the market. This suggests that traders are preparing for a sizeable move. See our latest analysis for Essent Group. Essent Group’s share price has pulled back 2.44% over the past day to $66.46, although the 90-day share price return of 10.71% and 1-year total shareholder return of 21.35% point to underlying momentum that options traders may be reacting...
NasdaqGS:CENX
NasdaqGS:CENXMetals and Mining

Century Aluminum (CENX) Could Be 39% Undervalued If Its Growth Narrative Holds

Century Aluminum (CENX) is back on investors’ radar after recent share price moves, including a 5.2% gain in the latest session and a decline over the past 3 months. The stock’s longer term returns remain elevated. See our latest analysis for Century Aluminum. At the current share price of $44.88, Century Aluminum’s recent 5.2% one day share price gain follows a period where the 90 day share price return declined 23.91%, while the 1 year total shareholder return sits at 111.90%. This...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

Celldex Therapeutics (CLDX) After Phase 2 Trial Results As Valuation Questions Come Into Focus

Celldex Therapeutics (CLDX) is in focus after releasing topline results from its Phase 2 clinical trial in prurigo nodularis, a development that gives investors new information on a key pipeline program. See our latest analysis for Celldex Therapeutics. The Phase 2 readout arrives after a period of strong momentum in Celldex Therapeutics' stock, with a 90 day share price return of 19.11% and a year to date share price return of 42.48%. The 1 year total shareholder return of 75.09% contrasts...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

Is Sirius XM Holdings (SIRI) Fully Valued After Strong Earnings And A Higher 2026 Outlook?

Sirius XM Holdings (SIRI) just posted second quarter results, reporting year over year growth in revenue and net income, record low churn, and a higher full year 2026 outlook for revenue, EBITDA, and free cash flow. See our latest analysis for Sirius XM Holdings. The latest earnings release and raised guidance triggered a sharp reaction, with Sirius XM Holdings’ share price falling 4.97% over the last day but still showing a 51% year to date share price return and a 53.84% total shareholder...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Has Nasdaq (NDAQ) Become A Bargain After Its Latest Earnings Update?

Nasdaq (NDAQ) has drawn fresh attention after reporting second quarter 2026 results with year over year growth in revenue, net income and earnings per share from continuing operations, alongside an updated dividend and share repurchase activity. See our latest analysis for Nasdaq. The latest earnings and dividend update comes after a strong 30-day share price return of 20.73%, while the year-to-date share price is still down 1.55% and the 3-year total shareholder return stands at 100.83%...
NYSE:VVX
NYSE:VVXAerospace & Defense

V2X (VVX) Following S&P Index Additions Still Looks Fully Valued

V2X (VVX) is drawing fresh attention after being added to multiple S&P indices, including the S&P 600 Industrials, S&P Composite 1500, S&P 1000, and S&P 600, a shift that can influence index tracking fund demand. See our latest analysis for V2X. The recent index additions come after a strong run in V2X's share price, with a 30 day share price return of 16.35% and a year to date share price return of 56.14%, while the 1 year total shareholder return of 83.09% points to momentum that has...
NasdaqGS:BUSE
NasdaqGS:BUSEBanks

First Busey (BUSE) Stock Looks Fairly Valued As Earnings Support Its Price

First Busey stock has delivered a 64.1% total return over the past three years, and at around US$31.28 a share the mixed signals on value now matter more. The Excess Returns intrinsic value estimate points to meaningful undervaluation, while the broader checklist of valuation metrics suggests a more balanced picture. Over the past three years, First Busey has returned 64.1%, which puts extra focus on whether the current price still offers a margin of safety. The company’s long term ability...
NYSE:MATX
NYSE:MATXShipping

Matson (MATX) Stock Looks Close To Fair Value Today

Matson stock has delivered strong long term returns, yet with the current price at US$203.65 and the broader checks pointing to an about right valuation, the shares no longer look like an obvious bargain. Matson has returned 206.9% over the past 5 years, which puts extra focus on whether the current price still reflects its long run earnings power. Future earnings growth and cash generation can support the current valuation, while any pressure on freight demand or shipping margins may...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

DexCom (DXCM) Stock May Be Below Fair Value Following Raised Guidance

DexCom stock has delivered a roughly 43.1% decline over the past five years, yet an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach currently points to a sizeable gap between the share price and that estimate. At the same time, the broader valuation checks send a more mixed message, so recent news around product approvals and digital health partnerships is now being weighed against what investors are paying for the stock. The roughly 43.1% share price decline over...
NYSE:GD
NYSE:GDAerospace & Defense

General Dynamics (GD) Stock Near Highs After Backlog And EPS Lift

General Dynamics stock barely moved in regular trading, up about 0.1% and still hovering near recent highs, even as the company reported one of its strongest defense and aerospace quarters in years. Q2 revenue reached US$14.1b and earnings per share were roughly US$4.29, with management lifting full year EPS guidance into the US$16.80 to US$16.90 range. For short term traders, that muted price action may feel underwhelming. For long term holders, the combination of higher earnings power and a...
NYSE:WOLF
NYSE:WOLFSemiconductor

Wolfspeed (WOLF) Names New Director As Fair Value Narrative Stays Below The Stock

Wolfspeed (WOLF) shares are reacting to a governance shift after the company appointed veteran technology executive Andreas “Andy” Mattes to its Board and as chair of the Compensation Committee on July 28, 2026. See our latest analysis for Wolfspeed. Wolfspeed’s governance update arrives after a volatile stretch, with the latest share price at $23.79, a 1-day share price return of 18.6% but a 30-day share price return down 50.7%. This suggests short-term momentum is trying to recover after a...
NYSE:SHAK
NYSE:SHAKHospitality

Shake Shack (SHAK) Faces Q2 Profit Pressure, Is It Still 21% Below Fair Value?

Recent expectations around Shake Shack (SHAK) Q2 2026 earnings, which point to higher revenue but a year-over-year decline in profits, have put the stock in focus as investors assess the upcoming August 5 release. See our latest analysis for Shake Shack. At a share price of US$63.07, Shake Shack has seen short term momentum build, with a 7 day share price return of 12.65% and a 30 day share price return of 12.58%. This follows a 90 day share price decline of 35.88% and a 1 year total...